Rodman & Renshaw analyst Amit Dayal is out with a new research note on shares of Gevo, Inc. (NASDAQ:GEVO), after the biofuel maker …
In a research report published Wednesday, H.C.
In a research report released Friday, Rodman & Renshaw analyst Amit Dayal reiterated a Buy rating on shares of Second Sight Medical Products Inc (NASDAQ:EYES), …
In a research report released Wednesday, Rodman & Renshaw analyst Amit Dayal reiterated a Buy rating on Second Sight Medical Products Inc (NASDAQ:EYES) with …
H.C.
